✦ LIBER ✦

A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21

✍ Scribed by Ramesh K. Ramanathan, Joe J. Stephenson, Glen J. Weiss, Linda A. Pestano, Ann Lowe, Alton Hiscox, Rafael A. Leos, Julie C. Martin, Lynn Kirkpatrick, Donald A. Richards

Book ID: 113064580
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 133 KB
Volume: 30
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-011-9739-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of taxol given as a 3-hour

Phase I trial of taxol given as a 3-hour infusion every 21 days

✍ Kris, M.G.; O'Connell, J.P.; Gralla, R.J. 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 101 KB

928 Phase I trial of the topoisomerase I

928 Phase I trial of the topoisomerase I inhibitor GG211 as a 72-hour infusion

✍ P. O’Dwyer; L. Pas-Arez; R. Kunka; D. DeMaria; J. Cassidy; S. Kaye; S. DePee; D. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 171 KB

A phase IB trial of 24-hour intravenous

A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers

✍ Baker, A. F.; Adab, K. N.; Raghunand, N.; Chow, H. H. S.; Stratton, S. P.; Squir 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 426 KB

535 Phase I study of a new Halichondrin

535 Phase I study of a new Halichondrin B analog, E7389, administered by 1-hour IV infusion every 21 days

✍ Y.A. Elsayed; L. Rosen; V. Rajeev; L. Wiggins; E. Liang; C. DesJardins; S. Woepp 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Phase I study of PM00104 (Zalypsis®) adm

Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors

✍ Massard, Christophe; Margetts, Jane; Amellal, Nadia; Drew, Yvette; Bahleda, Rati 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 171 KB

Erratum to: Phase I study of PM00104 (Za

Erratum to: Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors

✍ Massard, Christophe; Margetts, Jane; Amellal, Nadia; Drew, Yvette; Bahleda, Rati 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 49 KB